中文版 | English

在结果中检索

HFCAS OpenIR
（本次检索基于用户作品认领结果）

浏览/检索结果: 共2条，第1-2条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文
THORACIC CANCER, 2022
作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo;  Zhang, Yongchang;  Cai, Xiuyu;  Zhang, Shirong;  Lian, Bin;  Li, Wen;  Liu, Anwen;  Zhan, Ping;  Liu, Hongbing;  Lv, Tangfeng;  Miao, Liyun;  Min, Lingfeng;  Chen, Yu;  Yuan, Jingping;  Wang, Feng;  Jiang, Zhansheng;  Lin, Gen;  Pu, Xingxiang;  Rao, Chuangzhou;  Lv, Dongqing;  Yu, Zongyang;  Li, Xiaoyan;  Tang, Chuanhao;  Zhou, Chengzhi;  Xie, Congying;  Zhang, Junping;  Guo, Hui;  Chu, Qian;  Meng, Rui;  Wu, Jingxun;  Zhang, Rui;  Wang, Liping;  Zhu, Youcai;  Hu, Xiao;  Xie, Yanru;  Lin, Xinqing;  Cai, Jing;  Lan, Fen;  Feng, Huijing;  Wang, Lin;  Yao, Wang;  Shi, Xuefei;  Huang, Jianhui;  Chen, Huafei;  Zhang, Yinbin;  Sun, Pingli;  Wan, Bing;  Pang, Fei;  Xu, Zanmei;  Wang, Kai;  Xia, Yuanli;  Ye, Mingxiang;  Wang, Dong;  Wei, Qing;  Feng, Shuitu;  Zhou, Jianya;  Zhang, Jiexia;  Lv, Donglai;  Gao, Wenbin;  Kang, Jing;  Yu, Genhua;  Liang, Xianbin;  Yu, Chengtao;  Shi, Lin;  Yang, Nong;  Wu, Lin;  Hong, Zhuan;  Hong, Wei;  Fang, Meiyu;  Zhang, Yiping;  Lu, Yuanzhi;  Wang, Guansong;  Ma, Shenglin;  Si, Lu;  Fang, Wenfeng;  Song, Yong
收藏  |  浏览/下载：41/0  |  提交时间：2022/12/23
checkpoint inhibitor pneumonitis  Chinese experts consensus  immune checkpoint inhibitor-related adverse effects  
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文
THORACIC CANCER, 2022
作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo;  Wang, Qian;  Liu, Aijun;  Yu, Jinpu;  Fang, Wenfeng;  Zhong, Wenzhao;  Wang, Zhijie;  Zhang, Yongchang;  Liu, Jingjing;  Zhang, Shirong;  Cai, Xiuyu;  Liu, Anwen;  Li, Wen;  Zhan, Ping;  Liu, Hongbing;  Lv, Tangfeng;  Miao, Liyun;  Min, Lingfeng;  Chen, Yu;  Yuan, Jingping;  Wang, Feng;  Jiang, Zhansheng;  Lin, Gen;  Pu, Xingxiang;  Lin, Rongbo;  Liu, Weifeng;  Rao, Chuangzhou;  Lv, Dongqing;  Yu, Zongyang;  Lei, Lei;  Li, Xiaoyan;  Tang, Chuanhao;  Zhou, Chengzhi;  Zhang, Junping;  Xue, Junli;  Guo, Hui;  Chu, Qian;  Meng, Rui;  Wu, Jingxun;  Zhang, Rui;  Hu, Xiao;  Zhou, Jin;  Zhu, Zhengfei;  Li, Yongheng;  Qiu, Hong;  Xia, Fan;  Lu, Yuanyuan;  Chen, Xiaofeng;  Ge, Rui;  Dai, Enyong;  Han, Yu;  Pan, Weiwei;  Luo, Jiancheng;  Jia, Hongtao;  Dong, Xiaowei;  Pang, Fei;  Wang, Kai;  Wang, Liping;  Zhu, Youcai;  Xie, Yanru;  Lin, Xinqin;  Cai, Jing;  Wei, Jia;  Lan, Fen;  Feng, Huijing;  Wang, Lin;  Du, Yingying;  Yao, Wang;  Shi, Xuefei;  Niu, Xiaomin;  Yuan, Dongmei;  Yao, Yanwen;  Huang, Jianhui;  Zhang, Yinbin;  Sun, Pingli;  Wang, Hong;  Ye, Mingxiang;  Wang, Dong;  Wang, Zhaofeng;  Wan, Bing;  Lv, Donglai;  Wei, Qing;  Kang, Jin;  Zhang, Jiatao;  Zhang, Chao;  Yu, Genhua;  Ou, Juanjuan;  Shi, Lin;  Li, Zhongwu;  Liu, Zhefeng;  Liu, Jing;  Yang, Nong;  Wu, Lin;  Wang, Huijuan;  Jin, Gu;  Yang, Liu;  Wang, Guansong;  Fang, Meiyu;  Fang, Yong;  Li, Yuan;  Wang, Xiaojia;  Zhang, Yiping;  Ma, Shenglin;  Wang, Biyun;  Zhang, Xiaotian;  Song, Yong;  Lu, Yuanzhi
收藏  |  浏览/下载：35/0  |  提交时间：2022/12/22
fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase